Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Archit Organosys's Revenue for the
three
months ended in Jun. 2026 was ₹371 Mil. Archit Organosys's average Accounts Receivable for the
three
months ended in Jun. 2026 was ₹245 Mil.
Hence, Archit Organosys's Receivables Turnover for the
three
months ended in Jun. 2026 was 1.51.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Archit Organosys Receivables Turnover Related Terms
Archit Organosys Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Archit Organosys's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524640 vs DOW: Receivables Turnover Comparison
For the Chemicals subindustry, Archit Organosys's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Archit Organosys Receivables Turnover vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Archit Organosys's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Archit Organosys's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Archit Organosys (BOM:524640) has a Receivables Turnover of 1.51 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Archit Organosys and its competitors. According to the industry distribution chart, Archit Organosys ranks #645 out of 1583 companies in the Chemicals industry, placing it in the top 40.7%.
Is Archit Organosys' Receivables Turnover too high?
Archit Organosys' current Receivables Turnover is 1.51. The Chemicals industry median Receivables Turnover is 5.74. Archit Organosys' value of 1.51 is 73.7% below this industry median. Based on the distribution chart, Archit Organosys ranks #645 out of 1583 companies in the Chemicals industry, which is above the industry midpoint. Overall, Archit Organosys has a GF Score™ of 63/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Archit Organosys' Receivables Turnover compare to DOW?
According to the Chemicals industry distribution chart, Archit Organosys ranks #645 out of 1583 companies for Receivables Turnover. This puts Archit Organosys in the upper half of its industry. The industry median Receivables Turnover is 5.74. Archit Organosys' value of 1.51 is 73.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Chemicals company?
The median Receivables Turnover among Chemicals companies is 5.74, based on 1,583 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Archit Organosys's current Receivables Turnover of 1.51 is 73.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Archit Organosys and its competitors. For the Chemicals industry, the median Receivables Turnover is 5.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Archit Organosys's current Receivables Turnover is 1.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Archit Organosys stock overvalued right now?
Based on GuruFocus' analysis, Archit Organosys (BOM:524640) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹55.80, compared to a current price of ₹63.65 — trading 14.1% above its estimated fair value. The current Receivables Turnover is 1.51 and 73.7% below the Chemicals industry median of 5.74. Archit Organosys' overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Archit Organosys (BOM:524640), the current Receivables Turnover is 1.51 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Archit Organosys (BOM:524640) Overvalued in 2026?
Based on GuruFocus' analysis, Archit Organosys stock appears to be overvalued.
The current stock price of ₹63.65 is trading 14.1% above its estimated GF Value™ of ₹55.80.
GuruFocus considers Archit Organosys to be Modestly Overvalued.
Key valuation signals for BOM:524640:
Receivables Turnover: 1.51
GF Value™: ₹55.80 vs. price of ₹63.65 (14.1% above fair value)
Industry Position: 73.7% below the Chemicals median (#645 of 1583)
No single metric tells the full story. See the BOM:524640 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Archit Organosys Ltd is mainly engaged in the manufacturing and selling of various chemical products, including alkali chemicals, inorganic chemicals, organic chemicals, pesticides and insecticides, dyes, and dyestuff. The company mainly manufactures and trades chemicals such as Monochloro Acetic Acid (MCA), Sodium Monochloro Acetate (SMCA), Chloroacetyl Chloride, and Trichloroacetyl Chloride (TCAC). It operates in a single segment identified as manufacturing and trading of dyes, chemicals, and pigments. Geographically, it derives the majority of its revenue from India and also exports products to other countries.
63GF Score
Get the complete analysis for BOM:524640
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524640 has been successfully added to your 
